Can I get it?
Yes, if a doctor decides it is right for you. Avanafil 50/100/200mg is authorised in the EU and can be prescribed after a medical review.
Avanafil 50/100/200mgPrescription only
Online medical consultation for Avanafil 50/100/200mg.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid at any EU pharmacy under Directive 2011/24/EU.
- Onset as fast as 15–30 minutes
- The most recent PDE5 molecule
- Narrower side-effect profile in some studies
Start consultationStart consultation · €35
Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
What Avanafil 50/100/200mg is, and how to get treatment
Avanafil is a prescription tablet for erectile dysfunction, authorised across the EU since 2013 and the most recently approved of the tablets in this group. It works like the others by keeping the blood vessels in the penis relaxed so blood can flow in during sexual arousal. The EU product information says the usual 100 mg dose is taken about 15 to 30 minutes before sex. As with the rest of this group, it must never be taken with nitrate heart medicines.
Avanafil 50/100/200mg has been authorised for use in the EU since 21 June 2013, so a licensed doctor can prescribe it when it is clinically appropriate for you.
What can I take instead?
Our doctors review every Sexual health option and recommend what fits your history and goals.
See all Sexual health optionsWhat do the studies show?
Every trial behind Avanafil 50/100/200mg is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesVERIFIED EVIDENCE
Avanafil 50/100/200mg: evidence and regulatory guide.
WHAT IT IS
How it works
Avanafil blocks the PDE5 enzyme that normally ends an erection, letting the blood vessels in the penis stay relaxed and fill with blood when a man is sexually aroused.
- PDE5
DEVELOPMENT STAGE
EU-authorised medicine
Trial register3 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| TA-301 — randomised, double-blind, placebo-controlled Phase 3 trialNCT00790751 | Men with mild to severe generalised erectile dysfunction | 646 | Read out | 2012-04-01 |
| TA-302 — randomised, double-blind, placebo-controlled Phase 3 trialNCT00809471 | Men with type 1 or type 2 diabetes and erectile dysfunction | 390 | Read out | 2012-08-01 |
| EU registration programme — four randomised, double-blind, placebo-controlled trials of up to 3 months | General erectile dysfunction, diabetic erectile dysfunction, and erectile dysfunction after bilateral nerve-sparing radical prostatectomy | 1,774 | Read out | — |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, Trask B, Day WW. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med 2012;9(4):1122-1133. doi:10.1111/j.1743-6109.2011.02629.x (PMID 22248153)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 50 / 100 / 200 mg | Mean change in SEP2 and SEP3 success rates and in IIEF erectile function domain score significantly favoured every dose over placebo (p<=0.001) | 12 |
| 50 / 100 / 200 mg | Of 300 attempts made within 15 minutes of dosing, 64% to 71% were successful vs 27% on placebo | 12 |
| 50 / 100 / 200 mg | Of 80 attempts made more than 6 hours after dosing, 59% to 83% were successful vs 25% on placebo | 12 |
The 15-minute and 6-hour figures come from small subsets of attempts (300 and 80 respectively) inside a 12-week trial, so they are much less precise than the overall 12-week results.
Sources
Last reviewed 2026-07-27
- EMA EPAR — Spedra (avanafil), EMEA/H/C/002581, marketing authorisation issued 21/06/2013
- EMA — Spedra EPAR product information (SmPC sections 4.2, 4.8, 5.1; general-population success rates ~47% / 58% / 59% for 50 / 100 / 200 mg vs ~28% placebo)
- J Sex Med 2012 — Randomised, double-blind, placebo-controlled evaluation of avanafil (PMID 22248153)
- ClinicalTrials.gov — TA-301 avanafil Phase 3 trial (NCT00790751)
- ClinicalTrials.gov · NCT00790751
- ClinicalTrials.gov · NCT00809471
NAMED SAFETY SIGNALS
What has been reported with Avanafil 50/100/200mg.
Headache
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men — and named as one of the most frequently reported reactions across a safety database of 2,566 exposed subjects.
Flushing
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men.
Nasal congestion
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men. Sinus congestion is listed as uncommon.
Back pain
Listed as uncommon in the EU product information adverse-reaction table — between 1 in 1,000 and 1 in 100 men — although the safety summary names it among the most frequently reported reactions.
Dizziness and blurred vision
Both listed as uncommon in the EU product information — between 1 in 1,000 and 1 in 100 men.
Use with nitrates
Contraindicated with nitrate medicines and nitric-oxide donors, and in men with serious cardiovascular conditions such as recent heart attack, stroke or unstable angina.
FormOral tablet
FrequencyOn demand
ResultsActs in ~15–30 minutes
What you pay Hi-Doctor€35 one-off
IN 60 SECONDS
Avanafil 50/100/200mg at a glance
- A PDE5-inhibitor tablet taken by mouth
- Adult men with erectile dysfunction; sexual stimulation is still required
- One tablet 15 to 30 minutes before sex, at most one dose in 24 hours
- Nitrates and poppers are contraindicated: blood pressure can fall dangerously
- Hi-Doctor consultation fee; the medicine is paid separately at a pharmacy
BRAND FACTS
Spedra at a glance
Spedra is centrally authorised, so a single EU authorisation covers all 27 member states; it was granted on 21 June 2013 and is held by Menarini International Operations Luxembourg S.A. It is the EU brand for avanafil, the most recently authorised of the erectile-dysfunction tablets. Sexual stimulation is required for the medicine to work.
- MARKETING AUTHORISATION HOLDER
- Menarini International Operations Luxembourg S.A.
- EU-AUTHORISED INDICATIONS
- Erectile dysfunction in adult men — the inability to achieve or maintain an erection sufficient for satisfactory sexual performance
- PRESENTATIONS
- 50 mg tablets · 100 mg tablets · 200 mg tablets
About
What is Avanafil 50/100/200mg?
Spedra contains the active ingredient avanafil.
Active ingredient: Avanafil · Dosages: 50 / 100 / 200 mg on demand
Avanafil is the most recent PDE5 inhibitor, with fast onset (15–30 minutes) and a somewhat narrower side-effect profile in some studies. It's useful when timing flexibility matters.
It's prescribed at 50, 100 or 200 mg on demand, around 15–30 minutes before sexual activity. If there's no response, the doctor reassesses: dose adjustment, a switch to another PDE5, or evaluation of underlying causes — never a self-prescribed change.
HOW IT WORKS
What Avanafil 50/100/200mg does in your body
Avanafil inhibits the PDE5 enzyme, improving penile blood flow in response to sexual stimulation. Its rapid absorption gives it one of the fastest onsets in the class.
Arousal releases nitric oxide
Avanafil does nothing on its own. When you are sexually aroused, nerves and blood-vessel lining in the penis release a gas called nitric oxide. That release is the trigger for everything that follows, which is why the EU product information states that sexual stimulation is required for the tablet to work.
Nitric oxide raises cGMP
Nitric oxide switches on an enzyme that makes cyclic guanosine monophosphate, usually shortened to cGMP. cGMP is the chemical messenger that tells the smooth muscle inside the erectile tissue to relax. As that muscle relaxes, blood flows into the penis faster than it drains away, and an erection builds.
Avanafil blocks the cGMP breaker
An enzyme called phosphodiesterase type 5, or PDE5, normally breaks cGMP down and ends the erection. Avanafil is described in the EU label as a highly selective, potent, reversible inhibitor of PDE5, so cGMP lasts longer and an erection is easier to reach and to keep.
How it helps
How it helps.
Fastest onset
Can act in as little as 15–30 minutes.
Modern molecule
The newest PDE5, with fewer vasomotor effects in some profiles.
Doctor-screened
The dose is tailored to your response and current medication.
What to expect
How to take it.
On demand, shortly before sexual activity. The doctor tailors the dose to your response and current medication.
- Take it about 15–30 minutes before sexual activity
- The doctor starts from the dose that fits your case
- Never combine with nitrates
- If there's no response, the doctor reassesses — don't self-adjust
Doses your doctor can prescribe
- Available doses50 / 100 / 200 mg
- When~15–30 min before activity
Your schedule is personal
These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.
DAY TO DAY
Taking Avanafil 50/100/200mg day to day
Take it 15 to 30 minutes ahead
Swallow one tablet by mouth roughly 15 to 30 minutes before sexual activity. That is the timing given in the EU product information for the usual 100 mg dose, and the same window applies to the 50 mg and 200 mg strengths.
Arousal is still required
The tablet does not cause an erection by itself. The label is explicit that sexual stimulation is needed for a response, because avanafil only extends a chemical signal that arousal starts in the first place.
One dose in 24 hours
The maximum recommended dosing frequency is once per day. Taking a second tablet because the first seemed not to work is outside the licence and raises the risk of low blood pressure, dizziness and fainting.
Food is allowed, fat slows it
You can take avanafil with or without food. A high-fat meal delays the peak blood level by about 1.25 hours on average and lowers it by about 39%, so a heavy meal beforehand can push back the onset.
Avoid grapefruit juice
Grapefruit juice inhibits the CYP3A4 enzyme that clears avanafil, which would raise the amount in your blood. The label advises avoiding grapefruit juice in the 24 hours before a dose.
Be careful with alcohol
Alcohol combined with avanafil made the drop in diastolic blood pressure significantly larger than either alone in a crossover study. Drinking raises the chance of dizziness, light-headedness or fainting after a dose.
Report back to your prescriber
Tell the prescriber whether the dose worked, how it was tolerated and what else you take. Any change of strength, or a decision to stop, is theirs to make with you rather than something to try alone.
Safety first
Safety, in full.
Avanafil 50/100/200mg is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Side effects, by how often they happen
Stop and get urgent medical help if
seek medical help immediately
these need urgent attention, whatever the frequency
- An erection lasts 4 hours or more, which is priapism and can permanently damage penile tissue
- Sudden loss or disturbance of vision in one or both eyes
- Sudden reduction or loss of hearing, sometimes with ringing in the ears and dizziness
- Chest pain or chest tightness during or shortly after sex
- Fainting, near-fainting or severe light-headedness after a dose
- Swelling of the face, lips, tongue or throat, a rash, or difficulty breathing
Common
common (≥1/100 to <1/10)
roughly between 1 in 100 and 1 in 10 people
- Headache
- Flushing, a warm reddening of the face and neck
- Blocked nose
Uncommon
uncommon (≥1/1,000 to <1/100)
roughly between 1 in 1,000 and 1 in 100 people
- Dizziness or drowsiness
- Sinus headache
- Blurred vision
- Palpitations, a noticeable heartbeat
- Hot flushes
- Blocked sinuses, or breathlessness on exertion
- Indigestion, nausea, vomiting or stomach discomfort
- Back pain or muscle tightness
- Tiredness
- Raised liver enzymes, a faster heart rate or an abnormal heart tracing on testing
Rare
rare (≥1/10,000 to <1/1,000)
roughly between 1 in 10,000 and 1 in 1,000 people
- Chest pain or angina, a fast heartbeat
- High or low blood pressure
- Runny nose, congested airways or nosebleed
- Dry mouth, gastritis, lower abdominal pain or diarrhoea
- Rash
- Flank pain, muscle aches or muscle spasms
- Passing urine more often
- Penile discomfort, an unprompted erection or genital itching
- Weakness, swollen ankles or a flu-like feeling
- Insomnia, premature ejaculation or restlessness
Erectile dysfunction in adult men.
- Take one tablet about 15–30 minutes before sexual activity.
- Maximum one dose per day.
- Sexual stimulation is still required for it to work.
- A heavy or high-fat meal delays the onset of effect.
WHO SHOULD NOT TAKE IT, AND WHO NEEDS EXTRA CARE
- You use organic nitrates or nitric oxide donors in any form, including glyceryl trinitrate spray and amyl nitrite
- You take riociguat or another guanylate cyclase stimulator, because blood pressure can fall dangerously
- You take a potent CYP3A4 inhibitor such as ketoconazole, itraconazole, ritonavir, atazanavir, clarithromycin, indinavir, nefazodone, nelfinavir, saquinavir or telithromycin
- You have had a heart attack, a stroke or a life-threatening abnormal heart rhythm in the last 6 months
- Your resting blood pressure is below 90/50 mmHg or above 170/100 mmHg
- You have unstable angina, angina brought on by sex, or heart failure of New York Heart Association class 2 or above
- You have severe liver impairment (Child-Pugh class C) or severe kidney impairment (creatinine clearance below 30 mL/min)
- You have lost vision in one eye from non-arteritic anterior ischaemic optic neuropathy, or you have an inherited degenerative retinal disorder
- You are allergic to avanafil or to any of the tablet's other ingredients
- Do not combine it with other PDE5 inhibitors or other erectile-dysfunction treatments, because the combination is unstudied and raises the risk of prolonged erection; caution also applies if the penis is anatomically deformed, for example by angulation, cavernosal fibrosis or Peyronie's disease, or if you have a condition that predisposes to priapism such as sickle cell anaemia, multiple myeloma or leukaemia
When to seek urgent care
For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.
Medicines and substances that interact
| MEDICINE OR SUBSTANCE | WHAT CAN HAPPEN | WHAT THE DOCTOR DOES |
|---|---|---|
| Nitrates and nitric oxide donors (e.g. GTN spray, amyl nitrite) | Avanafil amplifies the blood-pressure-lowering effect of nitrates, which can become dangerous. | Absolute contraindication; the prescriber will not issue avanafil alongside nitrates. |
| Riociguat and other guanylate cyclase stimulators | Additive lowering of systemic blood pressure with no demonstrated clinical benefit. | Absolute contraindication; the prescriber chooses a different route for erectile dysfunction. |
| Potent CYP3A4 inhibitors (ketoconazole, ritonavir and similar) | Ketoconazole raised avanafil exposure about 14-fold and lengthened its half-life to roughly 9 hours. | Absolute contraindication; the prescriber checks every current medicine before issuing. |
| Moderate CYP3A4 inhibitors (erythromycin, diltiazem, verapamil, fluconazole) | Erythromycin roughly tripled avanafil exposure and lengthened its half-life to about 8 hours. | Caps the dose at 100 mg and no more than once every 48 hours. |
| Alpha-blockers (doxazosin, tamsulosin) | Additive widening of blood vessels can cause symptomatic low blood pressure in some men. | Starts avanafil at 50 mg, and only once you are stable on the alpha-blocker. |
| Other blood-pressure-lowering medicines (e.g. amlodipine, enalapril) | Small additive falls in blood pressure; amlodipine also raised avanafil exposure by about 60%. | Monitors blood pressure and warns you about dizziness on standing. |
| CYP3A4 inducers (rifampicin, carbamazepine, phenobarbital, efavirenz, bosentan) | May clear avanafil faster and reduce how well it works; this has not been studied. | Concomitant use is not recommended, so the prescriber reviews alternatives. |
| Grapefruit juice and alcohol | Grapefruit juice raises avanafil levels; alcohol deepens the fall in diastolic blood pressure. | Advises no grapefruit juice for 24 hours beforehand and caution with alcohol. |
Have a doctor review your caseThis is exactly what the doctor screens for before prescribing anything.
Read the full Avanafil 50/100/200mg safety summaryEVIDENCE
What the clinical trials found
Avanafil's EU licence rests on four randomised, double-blind, placebo-controlled trials in 1,774 men, the programme reported by Goldstein and colleagues in 2012.
General population of men with erectile dysfunction
Placebo was about 28%. The 50 mg dose gave about 47% and 200 mg about 59%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with erectile dysfunction · Single dose, measured at about 15 minutes
Time-to-onset study using the SEP3 measure. Placebo was 13.78% and the 200 mg dose gave 28.18%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with type 1 or type 2 diabetes and erectile dysfunction
Placebo was about 21%, and 100 mg gave about 34%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with erectile dysfunction after bilateral nerve-sparing radical prostatectomy
Placebo was about 9%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)These figures are averages across groups of men in trials, not a forecast for any one person. A placebo tablet also worked some of the time, so the gap between avanafil and placebo is the meaningful part rather than the raw percentage. Results varied sharply by underlying cause, with much lower success rates after prostate surgery than in the general group, and an individual response can sit anywhere around these averages.
ALTERNATIVES
Avanafil next to the other PDE5 inhibitors
| MEDICINE | HOW IT IS TAKEN | HOW OFTEN | TYPICAL DOSE RANGE | EU-AUTHORISED INDICATION | KEY EVIDENCE |
|---|---|---|---|---|---|
| Sildenafil | Tablet by mouth | As needed, up to once daily | 25 to 100 mg | Treatment of men with erectile dysfunction; sexual stimulation is required. | EAU-cited trials: 56 to 84% reported improved erections |
| Tadalafil | Tablet by mouth | As needed, or 5 mg once daily | 2.5 to 20 mg | Treatment of erectile dysfunction, and of the signs and symptoms of benign prostatic hyperplasia in adult men. | EAU-cited trials: 67 to 81% reported improved erections |
| Vardenafil | Tablet by mouth | As needed, up to once daily | 5 to 20 mg | Treatment of erectile dysfunction in adult men; sexual stimulation is required. | EAU-cited trials: 66 to 80% reported improved erections |
Not sure which one fits your case? The doctor reviews your history and tells you.
Start consultation · €35ACCESS AND COST
Getting Avanafil 50/100/200mg, and what it costs
Avanafil is prescription-only across the EU, so no pharmacy in any member state can supply it without a valid prescription. Who pays varies: the rows below record what each national medicines register or national formulary states, and say so plainly where the official source does not publish a reimbursement position.
What you pay Hi-Doctor
€35 one-off
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.
What the pharmacy charges
Hi-Doctor does not sell, stock or dispense medicines and does not set their price. The medicine is paid for separately at the pharmacy, and the amount depends on the country, the pack size, whether a generic is available and whether your health system covers it. The official national database linked in the table publishes the current authorised price.
| COUNTRY | HOW IT IS SUPPLIED | COVERED BY THE HEALTH SYSTEM? | OFFICIAL SOURCE |
|---|---|---|---|
| Spain | Prescription-only | Not stated by the national register | AEMPS CIMA |
Show the other countries
| Germany | Prescription-only | Classed as a lifestyle preparation | PharmNet.Bund AMIce |
|---|---|---|---|
| France | Prescription-only | Not reimbursed | Base de données publique des médicaments |
| Italy | Prescription-only | Restricted — see national criteria | AIFA Medicinali |
| Netherlands | Prescription-only | Not in the GVS reimbursement system | CBG-MEB Geneesmiddeleninformatiebank |
| Portugal | Prescription-only | Not stated by the national register | INFARMED Infomed |
| Belgium | Prescription-only | Not stated by the national register | FAGG-AFMPS medicines database |
| Ireland | Prescription-only | Not stated by the national register | HPRA Find a Medicine |
| Austria | Prescription-only | Not stated by the national register | BASG Medikamente Info Austria |
| Poland | Prescription-only | Not stated by the national register | Rejestr Produktów Leczniczych |
PRICING
You only pay if treatment is approved.
€35 for one sexual-health consultation. Paid once, with no recurring charge.
Sexual health
ONE-OFF
€35 one-off
One consultation, one doctor, one decision.
Nothing stored publicly, ever
Start consultation
Full refund if a review is not approved
WHAT'S INCLUDED
- Consultation reviewed by an EU-licensed doctor
- Electronic prescription if approved
- Full refund if not approved
Full refund if a review is not approved
If a review is not approved, we refund the €35 consultation fee in full.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
A licensed doctor reviews your case, not an algorithm
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
FREQUENTLY ASKED QUESTIONS
Questions about Avanafil 50/100/200mg.
OTHER SEXUAL HEALTH TREATMENTS
Explore related treatments.
SOURCES
Where this information comes from
- 01
Spedra (avanafil): EPAR medicine overview — European Medicines Agency, 2026
- 02
Spedra: EU Product Information (Summary of Product Characteristics and package leaflet) — European Medicines Agency, 2026
- 03
Spedra 100 mg tablets: Summary of Product Characteristics — electronic medicines compendium (Datapharm), 2026
- 04
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction — The Journal of Sexual Medicine 9(4):1122-33, 2012
- 05
EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction — European Association of Urology, 2026
- 06
Viagra (sildenafil): EPAR medicine overview — European Medicines Agency, 2026
- 07
Cialis (tadalafil): EPAR medicine overview — European Medicines Agency, 2026
- 08
Levitra (vardenafil): EPAR medicine overview — European Medicines Agency, 2025
- 09
CIMA: Spedra 50/100/200 mg comprimidos, authorised and marketed, prescription-only — AEMPS (Spanish Agency for Medicines and Medical Devices), 2026
- 10
Avanafil, human medicines with a currently valid German authorisation: 28 entries, Spedra 50, 100 and 200 mg tablets (Menarini International Operations Luxembourg S.A., EU/1/13/841) and parallel-distributed packs, all prescription-only — BfArM AMIce, public part, via PharmNet.Bund, Germany, 2026
- 11
§ 34 Abs. 1 SGB V: medicines used predominantly to improve sexual potency are excluded from statutory health insurance — Bundesministerium der Justiz, Germany, 2026
- 12
Base de données publique des médicaments: SPEDRA 50/100/200 mg, autorisation active, commercialisée, no reimbursement rate listed — ANSM / Ministère de la Santé (France), 2026
- 13
Banca Dati Farmaci: Spedra (avanafil), packs in classe C a totale carico dell'assistito and classe A with a therapeutic plan — AIFA (Italian Medicines Agency), 2026
- 14
Farmacotherapeutisch Kompas: avanafil (Spedra, Menarini Benelux), marked XGVS, not included in the GVS reimbursement system — Zorginstituut Nederland, 2026
- 15
INFOMED: Spedra (avanafil) 50/100/200 mg, Autorizado, at least one presentation marketed — INFARMED (Portuguese National Authority of Medicines), 2026
- 16
Geneesmiddelendatabank: Spedra 200 mg tabl., EU/1/13/841, availability recorded per pack, medisch voorschrift — FAGG / AFMPS (Belgian Federal Agency for Medicines and Health Products), 2026
- 17
Human Medicines authorised list: Spedra 50/100/200 mg tablets, registration status AU, supply through pharmacies only — HPRA (Health Products Regulatory Authority, Ireland), 2026
- 18
Medikamente Info Austria: Spedra 50/100/200 mg Tabletten, no discontinuation of marketing reported, repeat prescription, pharmacy supply — BASG (Austrian Federal Office for Safety in Health Care), 2026
- 19
Rejestr Produktów Leczniczych: Spedra (Avanafilum) 50/100/200 mg tabletki, centralised procedure, ATC G04BE10 — Ministry of Health / e-Zdrowie (Poland), 2026
Reviewed by Hi-Doctor's medical team · Last reviewed 2026-07-27 · Next review due 2027-07-27
This page is educational information about a medicine, not a recommendation to take it and not a substitute for a medical consultation. Only a licensed doctor who has reviewed your history can decide whether a treatment is appropriate for you.
Find out if it's right for you
See if Avanafil 50/100/200mg is appropriate for you.
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.